Promega Corporation

P450Glo® CYP2C19 and CYP2D6 Assays and Screening Systems: The Method of Choice for in...

P450Glo® CYP2C19 and CYP2D6 Assays and Screening Systems: The Method of Choice for in vitro P450 Assays

Share

  • Share
  • Print
  • Email
  • Download PDF

Abstract

The human cytochrome P450 enzymes CYP2C19 and CYP2D6 contribute substantially to the metabolism of therapeutic drugs. The P450-Glo® Assays for these enzymes enable researchers to assay activity and screen for P450 inhibition using a bioluminescent assay that minimizes background noise and is amenable to high-throughput applications.

Cell Notes 14, 20–24.

James J. Cali, Dongping MA, Mary Sobol, Troy Good and David Liu

Promega Corporation
Publication Date: 2006

Download Article (331 KB)

Prefer a different language?

Ihr ausgwähltes Land istGermany. Ihre ausgewählte Sprache istDeutsch. Bitte wählen Sie die Sprache aus:

Dies ist richtig, bitte weiter gehen zu »

Ich brauche weitere Hilfe

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.